BioEclipse Therapeutics CEO, Dr. Pamela Contag, is named in Top 50 Women Leaders of San Jose for 2024 by "Women We Admire" magazine. In San Jose, it’s all about technology and innovation. The five most prominent industries are hospitality, retail, healthcare, manufacturing, and professional services, particularly technical and scientific services....
Combination treatment with the novel adoptive Natural Killer-Like T (NK-T) cell therapy CRX100 and a tumor-specific oncolytic vaccinia virus generated responses and was well tolerated in a small cohort of patients with recurrent, platinum-resistant ovarian cancer, according to data from a phase 1 trial (NCT04282044) presented at the 2024 SGO...
BioEclipse Therapeutics™ today announced today the appointment of Mahmoud Mahmoudian, Ph.D., FRSC, to the BioEclipse Board of Directors. Dr. Mahmoudian, an industry veteran who served as a senior executive at Sumitomo Dainippon Pharma Oncology (Sumitomo Oncology), brings with him decades of industry experience spanning venture investing, business development, and identifying, incubating, and developing novel...
Best StartUp - This article showcases our top picks for the best San Francisco based Therapeutics companies. These startups and companies are taking a variety of approaches to innovating the Therapeutics industry, but are all exceptional companies well worth a follow. We tried to pick companies across the size spectrum from cutting...
StartUp Insights - Global Startup Heat Map highlights 5 Top Startups tackling Ovarian Cancer out of 140 The insights of this data-driven analysis are derived from the Big Data & Artificial Intelligence-powered StartUs Insights Discovery Platform, covering 2.093.000+ startups & scaleups globally. The platform gives you an exhaustive overview of emerging technologies &...